The impact of recipient cytokine genotype on acute rejection after renal transplantation.

被引:73
作者
Marshall, SE [1 ]
McLaren, AJ
Haldar, NA
Bunce, M
Morris, PJ
Welsh, KI
机构
[1] Churchill Hosp, Oxford Transplant Ctr, Oxford OX3 7LJ, England
[2] Oxford Radcliffe Hosp, Nuffield Dept Surg, Oxford, England
关键词
D O I
10.1097/00007890-200011270-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Acute allograft rejection remains an important cause of morbidity after kidney transplantation, and has een shown to be a crucial determinant of long-term graft function. As cytokines are major regulators of the immune system, genetic variation in cytokine production or activity may influence susceptibility to acute rejection. This study sought to determine the impact of recipient cytokine and cytokine receptor polymorphism on acute rejection after renal transplantation. Methods. A total of 209 cadaveric renal transplant recipients were selected for analysis according to the presence or absence of graft rejection in the first 30 days after transplantation. DNA was genotyped for 22 polymorphisms in 11 cytokine receptor genes using the polymerase chain reaction with sequence specific primers. Results were stratified by incidence and severity of rejection, and by HLA-DR mismatching. Results. No association between any polymorphism and the incidence or severity of acute rejection was detected. In particular, no association was seen with tumor necrosis factor or interleukin-10 genotype, either alone or in combination. Conclusions. We have failed to demonstrate any association between recipient cytokine genotype and acute rejection after cadaveric renal transplantation. Although more extensive studies may disprove these findings, it would seem premature to use recipient cytokine genotyping to predict transplant outcome, or to guide immunosuppressive therapy after transplantation.
引用
收藏
页码:1485 / 1491
页数:7
相关论文
共 41 条
[1]   Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection [J].
Abdallah, AN ;
Cucchi-Mouillot, P ;
Biteau, N ;
Cassaigne, A ;
Haras, D ;
Iron, A .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1999, 26 (04) :249-255
[2]  
[Anonymous], 1999, NAT GENET, V22, P1
[3]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[4]   The new genetics - The new genetics in clinical practice [J].
Bell, J .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7131) :618-620
[5]   CHARACTERIZATION OF POLYMORPHISMS OF AN INTERLEUKIN-1 RECEPTOR-TYPE-1 GENE (IL1RI) PROMOTOR REGION (P2) AND THEIR RELATION TO INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) [J].
BERGHOLDT, R ;
KARLSEN, AE ;
JOHANNESEN, J ;
HANSEN, PM ;
DINARELLO, CA ;
NERUP, J ;
POCIOT, F .
CYTOKINE, 1995, 7 (07) :727-733
[6]   Cytokine gene polymorphism in human disease: on-line databases [J].
Bidwell, J ;
Keen, L ;
Gallagher, G ;
Kimberly, R ;
Huizinga, T ;
McDermott, MF ;
Oksenberg, J ;
McNicholl, J ;
Pociot, F ;
Hardt, C ;
D'Alfonso, S .
GENES AND IMMUNITY, 1999, 1 (01) :3-19
[7]   MULTIPLE SIGNIFICANCE TESTS - THE BONFERRONI METHOD .10. [J].
BLAND, JM ;
ALTMAN, DG .
BRITISH MEDICAL JOURNAL, 1995, 310 (6973) :170-170
[8]   SSC POLYMORPHISMS IN INTERLEUKIN GENES [J].
BORISH, L ;
MASCALI, JJ ;
KLINNERT, M ;
LEPPERT, M ;
ROSENWASSER, LJ .
HUMAN MOLECULAR GENETICS, 1994, 3 (09) :1710-1710
[9]  
Brinkman BMN, 1996, J INFLAMM, V46, P32
[10]   Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) [J].
Bunce, M ;
ONeill, CM ;
Barnardo, MCNM ;
Krausa, P ;
Browning, MJ ;
Morris, PJ ;
Welsh, KI .
TISSUE ANTIGENS, 1995, 46 (05) :355-367